Related Experiment Video
Updated: May 10, 2026
07:23
Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Categorising methadone: Addiction and analgesia.
1School of Sociology, Research School of Social Sciences, Australian National University, Canberra ACT 0200, Australia.
The International Journal on Drug Policy
|June 18, 2013
Summary
Methadone is used for both pain relief and opioid addiction treatment, but medical language often separates these uses. This separation becomes difficult when patients require methadone for both conditions simultaneously.
Area of Science:
- Pharmacology
- Medical Sociology
- Pain Management
Background:
- Methadone was initially developed as an analgesic but is now primarily recognized for opioid addiction treatment through methadone maintenance therapy (MMT).
- The 1990s saw a resurgence of methadone as a painkiller due to the liberalization of opiate prescriptions for chronic pain.
- Current medical literature and guidelines often present methadone as two distinct entities based on its application: pain management versus addiction treatment.
Purpose of the Study:
- To examine the relationship between methadone as a painkiller and methadone as an addiction treatment.
- To analyze how medical discourse constructs and maintains distinctions between these two uses of methadone.
- To investigate the complexities and challenges in separating these roles, particularly in patients with co-occurring chronic pain and opioid dependence.
Main Methods:
- Literature review of recent medical research on methadone.
- Analysis of treatment guidelines concerning methadone use.
- Examination of medical discourse and patient categorization (addicts vs. non-addicts, pain sufferers vs. non-pain sufferers).
Main Results:
- Medical discourse often creates a separation between methadone for pain and methadone for addiction, classifying patients accordingly.
- Despite efforts to distinguish these uses, the pharmacological actions and clinical applications of methadone show significant overlap.
- The distinction between 'two methadones' is most challenged in cases where methadone maintenance therapy patients also require treatment for chronic pain.
Conclusions:
- The categorization of patients and the discourse surrounding methadone use complicate the separation of its analgesic and addiction treatment roles.
- The inherent similarities in methadone's action and application across different contexts challenge rigid distinctions.
- Clinical practice, especially in managing chronic pain among patients in methadone maintenance therapy, highlights the difficulties in maintaining a clear separation between the 'two methadones'.
Related Concept Videos
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:15Drug Abuse and Addiction: Pharmacological Phenomena
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
01:17Drug Dependence
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
01:22Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...